From research to clinical practice, our laboratory has developed both a national and international reputation in these areas of testing. We were involved in the development of, and were the first academic program in the U.S. to offer the Quad test for prenatal screening. We also served as the central laboratory in the FASTER Trial, a large-scale, national intervention trial sponsored by the National Institute of Health (NIH) to compare first and second trimester screening methods. We have now implemented a new generation of screening using cell-free DNA in maternal plasma.
Our laboratory is among the most experienced in the U.S. in the measurement of inhibin A, inhibin B and related proteins, and was the first to report on the use of inhibin types in prenatal screening and testing for ovarian reserve.
Working with our colleagues in the Prenatal Diagnosis Center, we offer the latest prenatal screening tests for Down syndrome and other neural tube defects, including:
- AMH/Inhibin A.
- Amniotic fluid AFP.
- AChE and HbF.
- Serum reflex.
For women having difficulty conceiving, working collaboratively with the physicians in Women & Infants' Fertility Center, we provide tests for such measurements as:
- Inhibin B.
- DHEA sulfate.
- Inhibin B.